The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Aggravating and Mitigating Patient Factors Affecting Mild to Moderate Atopic Dermatitis

중등도 이하 아토피 피부염에 영향을 미치는 환자 요인

  • Kang, Dong-Won (Department of Korean Medicine Ophthalmology, Otolaryngology and Dermatology, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Yoon-Bum (Department of Korean Medicine Ophthalmology, Otolaryngology and Dermatology, College of Korean Medicine, Kyung Hee University)
  • 강동원 (경희대학교 한의과대학 안이비인후피부과) ;
  • 김윤범 (경희대학교 한의과대학 안이비인후피부과)
  • Received : 2020.10.01
  • Accepted : 2020.10.27
  • Published : 2020.11.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : To investigate aggravating and mitigating factors of atopic dermatitis and to utilize the outcome in treatment planning. Methods : The research has a cross-sectional study design. Patients' SCORing Atopic Dermatitis (SCORAD) Index, demographic, physical characteristics, social history, serologic index and skin related instrumental measurements were analyzed with correlation and regression analysis method. Results : 48 patients in total were enrolled in the study. Skin Surface Hydration (SSH) and sex were found to be statistically significant aggravating and mitigating factors. As SSH increased, Total SCORAD (tSCORAD) and Objective SCORAD (oSCORAD) increased as well. As SSH decreased, tSCORAD and oSCORAD decreased as well. Female patient had a higher probability of suffering from severer subjective symptoms than that of male. Age, body mass index (BMI), alcohol consumption and smoking, transepidermal water loss (TEWL), IgE, IL-4, IL-5, IL-6, IFN-γ were found not to be statistically significant. There was no correlation between Subjective SCORAD (sSCORAD) and oSCORAD neither with Eczema Area and Severity Index (EASI). Conclusions : Increasing cutaneous moisture should be included in the treatment plan of atopic dermatitis. More emphasis should be put on alleviating subjective discomforts of female patients than that of male. Establishing separate strategies of managing objective eczema status and subjective discomforts respectively should be considered.

Keywords

References

  1. Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36(5):595-605. https://doi.org/10.1016/j.clindermatol.2018.05.007
  2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-22. https://doi.org/10.1016/S0140-6736(15)00149-X
  3. Mozaffari H, Pourpak Z, Pourseyed S, et al. Quality of life in atopic dermatitis patients. J Microbiol Immunol Infect. 2007;40(3):260-4.
  4. Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016;138(2):350-8 e351. https://doi.org/10.1016/j.jaci.2016.06.002
  5. Nomura T, Kabashima K. Advances in atopic dermatitis in 2015. J Allergy Clin Immunol. 2016;138(6):1548-55. https://doi.org/10.1016/j.jaci.2016.10.004
  6. Fonacier LS, Dreskin SC, Leung DY. Allergic skin diseases. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S138-49.
  7. Kim YH, Urm SH, Kim WK. Prevalence of Allergic Diseases and Risk Factors in Preschool Children, 2009. Pediatr Allergy Respir Dis. 2011;21(3):165-75. https://doi.org/10.7581/pard.2011.21.3.165
  8. Baek JO, Hong S, Son DK, Lee JR, Roh JY, Kwon HJ. Analysis of the prevalence of and risk factors for atopic dermatitis using an ISAAC questionnaire in 8,750 Korean children. Int Arch Allergy Immunol. 2013;162(1):79-85. https://doi.org/10.1159/000351403
  9. Park YM, Lee SY, Kim WK, et al. Risk factors of atopic dermatitis in Korean schoolchildren: 2010 international study of asthma and allergies in childhood. Asian Pac J Allergy Immunol. 2016;34(1):65-72.
  10. Park YM. Epidemiologic Study and Risk Factors of Atopic Dermatitis. Pediatr Allergy Respir Dis. 2011;21(2):74-7. https://doi.org/10.7581/pard.2011.21.2.74
  11. Choi WJ, Ko JY, Kim JW, et al. Prevalence and risk factors for atopic dermatitis: a cross-sectional study of 6,453 Korean preschool children. Acta Derm Venereol. 2012;92(5):467-71. https://doi.org/10.2340/00015555-1252
  12. Yi O, Kwon HJ, Kim H, et al. Effect of environmental tobacco smoke on atopic dermatitis among children in Korea. Environ Res. 2012;113:40-5. https://doi.org/10.1016/j.envres.2011.12.012
  13. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31. https://doi.org/10.1159/000247298
  14. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol. 2003;120(6):932-41. https://doi.org/10.1046/j.1523-1747.2003.12251.x
  15. Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS One. 2011;6(4):e17520. https://doi.org/10.1371/journal.pone.0017520
  16. Hill MK, Kheirandish Pishkenari A, Braunberger TL, Armstrong AW, Dunnick CA. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review. J Am Acad Dermatol. 2016;75(5):906-17. https://doi.org/10.1016/j.jaad.2016.07.002
  17. Park JG, Park HJ, Chae Y, Kim YK, Lee H, Kim K. Acupuncture Treatment for Symptom Management in Atopic Dermatitis: A Study Protocol for a Randomized, Participant- and Assessor-Blind, Sham-Controlled Trial. Evid Based Complement Alternat Med. 2019;2019:1907578.
  18. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD Index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-9.
  19. Oranje AP, Stalder JF, Taieb A, Tasset C, de Longueville M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol. 1997;8(1):28-34. https://doi.org/10.1111/j.1399-3038.1997.tb00139.x
  20. Schmitt J, Langan S, Williams HC, European Dermato-Epidemiology N. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120(6):1389-98. https://doi.org/10.1016/j.jaci.2007.08.011
  21. Bozek A, Reich A. Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA. Dermatology. 2017;233(1):16-22. https://doi.org/10.1159/000472711
  22. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-8. https://doi.org/10.1034/j.1600-0625.2001.100102.x
  23. Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316-21. https://doi.org/10.1111/bjd.15641
  24. Barbier N, Paul C, Luger T, et al. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol. 2004;150(1):96-102. https://doi.org/10.1111/j.1365-2133.2004.05696.x
  25. Barel AO, Clarys P. In vitro calibration of the capacitance method (Corneometer CM 825) and conductance method (Skicon-200) for the evaluation of the hydration state of the skin. Skin Res Technol. 1997;3(2):107-13. https://doi.org/10.1111/j.1600-0846.1997.tb00171.x
  26. Hwang SW, Kang JH, Seol JE, Seo JK, Lee DBR, Sung HS. The Correlation between SCORAD Index and Instrumental Assessment in Evaluation of Atopic Dermatitis Severity. Korean J Dermatol. 2010;48(4):266-71.
  27. Miteva M, Richter S, Elsner P, Fluhr JW. Approaches for optimizing the calibration standard of Tewameter TM 300. Exp Dermatol. 2006;15(11):904-12. https://doi.org/10.1111/j.1600-0625.2006.00482.x
  28. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73. https://doi.org/10.1038/jid.2010.251
  29. Brunekreef B, Stewart AW, Anderson HR, et al. Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease: a global relationship in ISAAC phase 3. Environ Health Perspect. 2009;117(11):1791-8. https://doi.org/10.1289/ehp.0800467
  30. Ellwood P, Asher MI, Garcia-Marcos L, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Thorax. 2013;68(4):351-60. https://doi.org/10.1136/thoraxjnl-2012-202285
  31. Foliaki S, Pearce N, Bjorksten B, et al. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol. 2009;124(5):982-9. https://doi.org/10.1016/j.jaci.2009.08.017
  32. Mitchell EA, Beasley R, Keil U, Montefort S, Odhiambo J, Group IPTS. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme. Thorax. 2012;67(11):941-9. https://doi.org/10.1136/thoraxjnl-2011-200901
  33. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483-91. https://doi.org/10.1183/09031936.95.08030483
  34. Holm EA, Wulf HC, Thomassen L, Jemec GB. Assessment of atopic eczema: clinical scoring and noninvasive measurements. Br J Dermatol. 2007;157(4):674-80. https://doi.org/10.1111/j.1365-2133.2007.08101.x
  35. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008;121(6):1337-43. https://doi.org/10.1016/j.jaci.2008.01.022
  36. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51. https://doi.org/10.1016/j.jaad.2013.10.010
  37. Ziyab AH, Raza A, Karmaus W, et al. Trends in eczema in the first 18 years of life: results from the Isle of Wight 1989 birth cohort study. Clin Exp Allergy. 2010;40(12):1776-84. https://doi.org/10.1111/j.1365-2222.2010.03633.x
  38. Schultz Larsen F, Hanifin JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1992;176:7-12.
  39. Vlaski E, Stavric K, Isjanovska R, Seckova L, Kimovska M. Overweight hypothesis in asthma and eczema in young adolescents. Allergol Immunopathol (Madr). 2006;34(5):199-205. https://doi.org/10.1157/13094027
  40. Sybilski AJ, Raciborski F, Lipiec A, et al. Obesity--a risk factor for asthma, but not for atopic dermatitis, allergic rhinitis and sensitization. Public Health Nutr. 2015;18(3):530-36. https://doi.org/10.1017/S1368980014000676
  41. Lee SI, Shin MH, Lee HB, et al. Prevalences of symptoms of asthma and other allergic diseases in korean children: a nationwide questionnaire survey. J Korean Med Sci. 2001;16(2):155-64. https://doi.org/10.3346/jkms.2001.16.2.155
  42. Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol. 2011;127(5):1180-6 e1181. https://doi.org/10.1016/j.jaci.2011.01.063
  43. Mitchell EA, Beasley R, Bjorksten B, et al. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy. 2013;43(1):73-84. https://doi.org/10.1111/cea.12024
  44. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199(1):15-24. https://doi.org/10.1006/cimm.1999.1594
  45. Kerkhof M, Koopman LP, van Strien RT, et al. Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy. 2003;33(10):1336-41. https://doi.org/10.1046/j.1365-2222.2003.01751.x
  46. Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70(1):3-11. https://doi.org/10.1016/j.jdermsci.2013.02.001
  47. Arbes SJ, Jr., Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377-83. https://doi.org/10.1016/j.jaci.2005.05.017
  48. Park GH, Park JH, Hwang YH, Sung MS, Kim SW. The correlation between the severity of atopic dermatitis classified by SCORing atopic dermatitis Index and the laboratory tests. Allergy Asthma Respir Dis. 2013;1(1):79-83. https://doi.org/10.4168/aard.2013.1.1.79